Beijing Tiantan Biological Products Co., Ltd. Share Price
Equities
600161
CNE000000WF9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.66 CNY | -0.20% |
|
+1.34% | -4.10% |
Capitalization | 38.88B 5.42B 4.64B 4.32B 4.02B 7.42B 465B 8.25B 51.76B 19.79B 218B 20.34B 19.92B 799B | P/E ratio 2025 * |
22.9x | P/E ratio 2026 * | 20.1x |
---|---|---|---|---|---|
Enterprise value | 34.66B 4.84B 4.13B 3.85B 3.58B 6.62B 415B 7.36B 46.15B 17.64B 194B 18.13B 17.76B 713B | EV / Sales 2025 * |
5.11x | EV / Sales 2026 * | 4.37x |
Free-Float |
46.44% | Yield 2025 * |
0.44% | Yield 2026 * | 0.59% |
More valuation ratios
* Estimated data
More news
1 day | -0.20% | ||
1 week | +1.34% | ||
Current month | +2.45% | ||
1 month | -0.76% | ||
3 months | -12.51% | ||
6 months | +3.04% | ||
Current year | -4.10% |
1 week | 19.51 | ![]() | 20.21 |
1 month | 18.88 | ![]() | 20.21 |
Current year | 18.88 | ![]() | 23.61 |
1 year | 18.88 | ![]() | 27.6 |
3 years | 16.11 | ![]() | 27.6 |
5 years | 12.44 | ![]() | 37.15 |
10 years | 6.53 | ![]() | 37.15 |
Manager | Title | Age | Since |
---|---|---|---|
Bo Tian
IRC | Investor Relations Contact | - | 28/02/2006 |
Xiang Ci
SEC | Corporate Secretary | 46 | 31/12/2002 |
Yi Zhang
DFI | Director of Finance/CFO | 55 | 25/04/2017 |
Director | Title | Age | Since |
---|---|---|---|
Hui Chuan Yang
CHM | Chairman | 58 | 04/12/2022 |
Li Gang Hu
BRD | Director/Board Member | 51 | 24/05/2017 |
Jing Jin Zhu
CHM | Chairman | 63 | 31/10/2016 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.66% | 0 M€ | -19.71% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.20% | +1.34% | -17.29% | +9.99% | 5.42B | ||
-0.61% | -0.76% | -20.24% | -16.34% | 76.69B | ||
+1.43% | +3.72% | -47.44% | -7.60% | 59.99B | ||
-2.13% | +5.70% | +29.69% | +27.50% | 54.72B | ||
-0.96% | +1.21% | +18.22% | +97.45% | 37.99B | ||
-0.83% | +1.01% | -43.32% | -37.65% | 19.67B | ||
+0.37% | -6.55% | +110.04% | +120.99% | 17.54B | ||
-2.23% | +16.91% | +62.89% | +752.43% | 17.06B | ||
-0.04% | -.--% | +68.37% | +138.03% | 14.02B | ||
-2.49% | +0.20% | +10.11% | -15.28% | 13.28B | ||
Average | -1.07% | +0.82% | +17.10% | +106.95% | 31.64B | |
Weighted average by Cap. | -1.19% | +1.12% | +3.38% | +61.65% |
2025 * | 2026 * | |
---|---|---|
Net sales | 6.78B 946M 809M 753M 701M 1.29B 81.17B 1.44B 9.03B 3.45B 38B 3.55B 3.47B 139B | 7.65B 1.07B 912M 850M 790M 1.46B 91.55B 1.62B 10.18B 3.89B 42.87B 4B 3.92B 157B |
Net income | 1.72B 240M 205M 191M 178M 329M 20.61B 365M 2.29B 877M 9.65B 901M 882M 35.4B | 1.96B 273M 234M 218M 202M 374M 23.43B 415M 2.61B 997M 10.97B 1.02B 1B 40.25B |
Net Debt | -4.21B -588M -503M -468M -435M -804M -50.42B -894M -5.61B -2.14B -23.61B -2.2B -2.16B -86.6B | -5.47B -764M -653M -608M -566M -1.05B -65.51B -1.16B -7.29B -2.79B -30.67B -2.86B -2.8B -113B |
More financial data
* Estimated data
Employees
5,298
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
11/07/25 | 19.66 ¥ | -0.20% | 12,941,180 |
10/07/25 | 19.70 ¥ | +0.05% | 10,340,320 |
09/07/25 | 19.69 ¥ | +0.10% | 15,854,650 |
08/07/25 | 19.67 ¥ | -0.61% | 17,942,040 |
07/07/25 | 19.79 ¥ | +2.01% | 30,613,790 |
End-of-day quote Shanghai S.E., July 10, 2025
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.66CNY
Average target price
28.00CNY
Spread / Average Target
+42.42%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600161 Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition